These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9242324)

  • 1. Risk factors for onset of cutaneous and mucocutaneous leishmaniasis in Bolivia.
    Alcais A; Abel L; David C; Torrez ME; Flandre P; Dedet JP
    Am J Trop Med Hyg; 1997 Jul; 57(1):79-84. PubMed ID: 9242324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous and mucocutaneous leishmaniasis in travellers and migrants: a 20-year GeoSentinel Surveillance Network analysis.
    Boggild AK; Caumes E; Grobusch MP; Schwartz E; Hynes NA; Libman M; Connor BA; Chakrabarti S; Parola P; Keystone JS; Nash T; Showler AJ; Schunk M; Asgeirsson H; Hamer DH; Kain KC;
    J Travel Med; 2019 Dec; 26(8):. PubMed ID: 31553455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for a major gene controlling susceptibility to tegumentary leishmaniasis in a recently exposed Bolivian population.
    Alcaïs A; Abel L; David C; Torrez ME; Flandre P; Dedet JP
    Am J Hum Genet; 1997 Oct; 61(4):968-79. PubMed ID: 9382111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fifteen years of cutaneous and mucocutaneous leishmaniasis in Bolivia: a retrospective study.
    David C; Dimier-David L; Vargas F; Torrez M; Dedet JP
    Trans R Soc Trop Med Hyg; 1993; 87(1):7-9. PubMed ID: 8465401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active surveillance of American tegumentary leishmaniasis in endemic areas in rural Bolivia.
    Tedesqui VL; Calleja GN; Parra R; Pabón JP; Bóia MN; Carvalho-Costa FA
    Rev Soc Bras Med Trop; 2012 Feb; 45(1):30-4. PubMed ID: 22370825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for mucosal manifestation of American cutaneous leishmaniasis.
    Machado-Coelho GL; Caiaffa WT; Genaro O; Magalhães PA; Mayrink W
    Trans R Soc Trop Med Hyg; 2005 Jan; 99(1):55-61. PubMed ID: 15550262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and immunological characteristics of tegumentary leishmaniasis cases in Bolivia.
    Ballart C; Torrico MC; Vidal G; Torrico F; Lozano D; Gállego M; Pinto L; Rojas E; Aguilar R; Dobaño C; Ares-Gomez S; Picado A
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009223. PubMed ID: 33667232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generic sodium stibogluconate is as safe and effective as branded meglumine antimoniate, for the treatment of tegumentary leishmaniasis in Isiboro Secure Park, Bolivia.
    Bermúdez H; Rojas E; Garcia L; Desjeux P; Dujardin JC; Boelaert M; Chappuis F
    Ann Trop Med Parasitol; 2006 Oct; 100(7):591-600. PubMed ID: 16989685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On 113 cases of cutaneous leishmaniasis and mucocutaneous leishmaniasis observed in Bolivia. Sero-immunologic study of 71 cases].
    Desjeux P; Quilici M; Lapierre J
    Bull Soc Pathol Exot Filiales; 1974; 67(4):387-95. PubMed ID: 4480529
    [No Abstract]   [Full Text] [Related]  

  • 10. Mucocutaneous leishmaniasis: a clinicopathologic classification.
    Sangueza OP; Sangueza JM; Stiller MJ; Sangueza P
    J Am Acad Dermatol; 1993 Jun; 28(6):927-32. PubMed ID: 8496456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous, mucocutaneous and visceral leishmaniasis in Sweden from 1996-2016: a retrospective study of clinical characteristics, treatments and outcomes.
    Glans H; Dotevall L; Söbirk SK; Färnert A; Bradley M
    BMC Infect Dis; 2018 Dec; 18(1):632. PubMed ID: 30526519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular alterations in patients with cutaneous and mucocutaneous leishmaniasis.
    Wunderle II; de Kaspar HM; Cabrera E; de Arias AR; Froehlich SJ; de Bilbao NV; Insfran NS; Azorero RM; Klauss V
    Trop Doct; 2003 Apr; 33(2):112-5. PubMed ID: 12680552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rural campaign to diagnose and treat mucocutaneous leishmaniasis in Bolivia.
    Dedet JP; Melogno R; Cardenas F; Valda L; David C; Fernandez V; Torrez ME; Dimier-David L; Lyevre P; Villareal ME
    Bull World Health Organ; 1995; 73(3):339-45. PubMed ID: 7614666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MOLECULAR CHARACTERIZATION OF AMERICAN CUTANEOUS LEISHMANIASIS IN THE TRI‑BORDER AREA OF ASSIS BRASIL, ACRE STATE, BRAZIL.
    Teles CB; Medeiros JF; Santos AP; Freitas LA; Katsuragawa TH; Cantanhêde LM; Ferreira Rde G; Camarg LM
    Rev Inst Med Trop Sao Paulo; 2015; 57(4):343-7. PubMed ID: 26422160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and epidemiological characteristics of cutaneous leishmaniasis in Sri Lanka.
    Iddawela D; Vithana SMP; Atapattu D; Wijekoon L
    BMC Infect Dis; 2018 Mar; 18(1):108. PubMed ID: 29510669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential immune regulation of activated T cells between cutaneous and mucosal leishmaniasis as a model for pathogenesis.
    Carvalho LP; Passos S; Bacellar O; Lessa M; Almeida RP; Magalhães A; Dutra WO; Gollob KJ; Machado P; de Jesus AR
    Parasite Immunol; 2007 May; 29(5):251-8. PubMed ID: 17430548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiological, clinical and biological features of mucocutaneous leishmaniasis in Bolivia after a 221 patient sample].
    Dimier-David L; David C; Muñoz M; Vargas F; Bustillos R; Valda L; Dedet JP
    Bull Soc Pathol Exot; 1993; 86(2):106-11. PubMed ID: 8353467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leishmaniasis in Yemen: a clinicoepidemiological study of leishmaniasis in central Yemen.
    Al-Kamel MA
    Int J Dermatol; 2016 Aug; 55(8):849-55. PubMed ID: 26547479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and epidemiological features of leishmaniasis in northwestern-Argentina through a retrospective analysis of recent cases.
    García Bustos MF; González-Prieto G; Ramos F; Mora MC; Hashiguchi Y; Parodi C; Basombrío MA; Moreno S; Monroig S; Beckar J; Jaime D; Sajama J; Yeo M; Marco JD; Locatelli FM; Barrio A
    Acta Trop; 2016 Feb; 154():125-32. PubMed ID: 26611809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Leishmaniasis en Bolivia. Comprehensive review and current status in Tarija, in the border with Argentina].
    Mollinedo JS; Mollinedo Z; Magne M; Gironda WJ; Salomón ÓD
    Biomedica; 2020 May; 40(Supl. 1):45-61. PubMed ID: 32463608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.